Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma

被引:179
|
作者
Kendall, BS
Ronnett, BM
Isacson, C
Cho, KR
Hedrick, L
Diener-West, M
Kurman, RJ
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pathol & Gynecol Obstet, Baltimore, MD 21287 USA
[3] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Biostat, Baltimore, MD 21287 USA
关键词
endometrial carcinoma; endometrial hyperplasia; atypical hyperplasia; reproducibility;
D O I
10.1097/00000478-199808000-00012
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Many studies have attempted to identify histologic features that aid in the distinction of atypical hyperplasia (AH) from hyperplasia without atypia and well-differentiated endometrioid carcinoma, but few have evaluated the reproducibility of these diagnoses. Five pathologists independently reviewed 100 endometrial biopsy and curettage specimens chosen to represent the entire spectrum of proliferative lesions of the endometrium, including proliferative endometrium (PEM), hyperplasia without atypia, AH, and well-differentiated endometrioid carcinoma. Slides were reviewed twice for diagnosis, with an intervening evaluation of a checklist of histologic features. Intraobserver and interobserver agreement were assessed using the kappa statistic. Intraobserver kappa values ranged from 0.67 to 0.89 (76% to 89% agreement). Interobserver kappa values by diagnostic category were: proliferative endometrium: 0.86; hyperplasia without atypia: 0.60; AH: 0.47; well-differentiated endometrioid carcinoma: 0.83; with a kappa value of 0.69 for all cases combined. Associations between the selected histologic features and the given diagnoses for each pathologist were analysed using multiple logistic regressions to identify features that were useful for distinguishing among diagnostic categories. Histologic features determined by univariable and multivariable analyses that were found to be most associated with distinguishing diagnostic categories were: proliferative endometrium versus hyperplasia without atypia: gland crowding (univariable, multivariable), and gland branching (univariable); hyperplasia without atypia versus AH: presence of nucleoli (univariable, multivariable), nuclear enlargement (univariable), vesicular chromatin change (univariable), nuclear pleomorphism (univariable), chromatin irregularities (univariable), and lass of polarity (univariable); hyperplasia without atypia versus carcinoma: glandular confluence/complex cribriform pattern (univariable, multivariable), stromal alteration (univariable, multivariable), and necrosis (univariable). In summary, interobserver agreement was good but was lowest for AH. Only the presence of nucleoli was strongly associated with distinction of AH from hyperplasia without atypia, Individual pathologists use additional features to diagnose atypia, but these features are not consistently associated with that diagnosis. Cribriform architectural pattern and stromal alteration were associated with the distinction of well-differentiated endometrioid carcinoma from AH.
引用
收藏
页码:1012 / 1019
页数:8
相关论文
共 50 条
  • [21] Factors affect the outcome of IVF and the recurrence of the endometrial disease of patients with atypical endometrial hyperplasia (AEH) and early well-differentiated endometrial adenocarcinoma (EC)
    Li, H.
    Song, X.
    Li, R.
    Qiao, J.
    HUMAN REPRODUCTION, 2018, 33 : 251 - 251
  • [22] Factors affect the outcome of IVF and the recurrence of the endometrial disease of patients with atypical endometrial hyperplasia (AEH) and early well-differentiated endometrial adenocarcinoma(EC)
    Li, H.
    Song, X.
    Li, R.
    Qiao, J.
    HUMAN REPRODUCTION, 2018, 33 : 251 - 251
  • [23] Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma
    Jing, Chu-Yu
    Li, Sheng-Nan
    Shan, Bo-Er
    Zhang, Wei
    Tian, Wen-Juan
    Ren, Yu-Lan
    Wang, Hua-Ying
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [24] Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma
    Jing, Chu-Yu
    Li, Sheng-Nan
    Shan, Bo-Er
    Zhang, Wei
    Tian, Wen-Juan
    Ren, Yu-Lan
    Wang, Hua-Ying
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [25] Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins
    Witkiewicz, Agnieszka K.
    McConnell, Thomas
    Potoczek, Magdalena
    Emmons, Robert V. B.
    Kurman, Robert J.
    HUMAN PATHOLOGY, 2010, 41 (01) : 26 - 32
  • [26] A COMPARATIVE MORPHOMETRIC AND CYTOPHOTOMETRIC STUDY OF ENDOMETRIAL HYPERPLASIA, ATYPICAL HYPERPLASIA, AND ENDOMETRIAL CARCINOMA
    NORRIS, HJ
    BECKER, RL
    MIKEL, UV
    HUMAN PATHOLOGY, 1989, 20 (03) : 219 - 223
  • [27] Concurrent endometrial carcinoma in Chinese women with a preoperative diagnosis of atypical endometrial hyperplasia
    Chang, Y.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 99 - 100
  • [28] Multifractal Spectrum Differentiation of Well-Differentiated Adenocarcinoma from Complex Atypical Hyperplasia of the Uterus
    Barwad, Adarsh
    Dey, Pranab
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2012, 34 (02): : 105 - 108
  • [29] The combination of gonadotropin releasing hormone agonist and levonorgestrel-release intrauterine device/aromatase inhibitor for severe atypical hyperplasia and well-differentiated endometrial carcinoma
    Yu, M.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 94 - 94
  • [30] Factors Predicting Response to Progestin Treatment for Complex Atypical Hyperplasia/Well Differentiated Endometrial Carcinoma in Premenopausal Patients
    Aoyama, C.
    Penner, K.
    Ostrzega, N.
    Rao, J.
    Walsh, C.
    Dorigo, O.
    Cass, I.
    Balzer, B.
    Holschneider, C.
    MODERN PATHOLOGY, 2011, 24 : 236A - 236A